MY140507A - Quinazoline derivatives, pharmaceutical compositions containing them, processes for their preparation and their use in the production of an antiangiogenic and/or vascular permeability reducing effect - Google Patents

Quinazoline derivatives, pharmaceutical compositions containing them, processes for their preparation and their use in the production of an antiangiogenic and/or vascular permeability reducing effect

Info

Publication number
MY140507A
MY140507A MYPI20000501A MY140507A MY 140507 A MY140507 A MY 140507A MY PI20000501 A MYPI20000501 A MY PI20000501A MY 140507 A MY140507 A MY 140507A
Authority
MY
Malaysia
Prior art keywords
alkyl
alkylsulphonyl
amino
compounds
formula
Prior art date
Application number
Inventor
Hennequin Laurent Francois Andre
Ple Patrick
Stokes Elaine Sophie Elizabeth
Mckerrecher Darren
Original Assignee
Astrazeneca Uk Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Uk Ltd filed Critical Astrazeneca Uk Ltd
Priority to MYPI20000501 priority Critical patent/MY140507A/en
Publication of MY140507A publication Critical patent/MY140507A/en

Links

Abstract

THE INVENTION RELATES TO THE USE OF COMPOUNDS OF THE FORMULA 1:WHEREIN RING C IS AN 8, 9, 10, 12 OR 13-MEMBERED BICYCLIC OR TRICYCLIC MOIETY WHICH OPTIONALLY MAY CONTAIN 1-3 HETEROATOMS SELECTED INDEPENDENTLY FROM O, N AND S; Z IS -O-, -NH-, -S-, -CH()- OR A DIRECT BOND; N IS 0-5; M IS 0-3; R2 REPRESENTS HYDROGEN, HYDROXY, HALOGENO, CYANO, NITRO, TRIFLUOROMETHYL, C()ALKYL, C()ALKOXY, C()ALKYLSULPHANYL, -NR3R4 (WHEREIN R3 AND R4, WHICH MAY BE THE SAME OR DIFFERENT, EACH REPRESENTS HYDROGEN OR C()ALKYL), OR R5X1- (WHEREIN X1 AND R5 ARE AS DEFINED HEREIN; R1 REPRESENTS HYDROGEN, OXO, HALOGENO, HYDROXY, C()ALKOXY, C()ALKYL, C()ALKOXYMETHYL, C()ALKANOYL, C()HALOALKYL, CYANO, AMINO, C()ALKENYL, C()ALKYNYL, C()ALKANOYLOXY, NITRO, C()ALKANOYLAMINO, C()ALKOXYCARBONYL, C()ALKYLSULPHANYL, C()ALKYLSULPHINYL, C()ALKYLSULPHONYL, CARBAMOYL, N-C()ALKYLCARBAMOYL, N, N-DI(C()ALKYL)CARBAMOYL, AMINOSULPHONYL, N-C()ALKYLAMINOSULPHONYL, N, N-DI(C()ALKYL)AMINOSULPHONYL, N-(C()ALKYLSULPHONYL)AMINO, N-(C()ALKYLSULPHONYL)-N-(C()ALKYL)AMINO, N, N-DI(C()ALKYLSULPHONYL)AMINO, A C()ALKYLENE CHAIN JOINED TO TWO RING C CARBON ATOMS, C()ALKANOYLAMINOC()ALKYL, CARBOXY OR A GROUP R56X10 (WHEREIN X10 AND R56 ARE AS DEFINED HEREIN); AND SALTS THEREOF, IN THE MANUFACTURE OF A MEDICAMENT FOR USE IN THE PRODUCTION OF AN ANTIANGGIOGENIC AND/OR VASCULAR PERMEABILITY REDUCING EFFECT IN WARM-BLOODED ANIMALS, PROCESSES FOR THE PRAPARATION OF SUCH COMPOUNDS, PHARMACEUTICAL COMPOSITIONS CONTAINING A COMPOUND OF FORMULA 1 OR A PHARMACEUTICALLY ACCEPTABLE SALT TEHREOF AS ACTIVE INGREDIENT AND COMPOUNDS OF FORMULA 1. THE COMPOUNDS OF FORMULA 1AND THE PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF INHIBIT THE EFFECTS OF VEGF, A PROPERTY OF VALUE IN THE TREATMENT OF A NUMBER OF DISEASES STATES INCLUDING CANCER AND RHEUMATOID ARTHRITIS.
MYPI20000501 2000-02-11 2000-02-11 Quinazoline derivatives, pharmaceutical compositions containing them, processes for their preparation and their use in the production of an antiangiogenic and/or vascular permeability reducing effect MY140507A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MYPI20000501 MY140507A (en) 2000-02-11 2000-02-11 Quinazoline derivatives, pharmaceutical compositions containing them, processes for their preparation and their use in the production of an antiangiogenic and/or vascular permeability reducing effect

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MYPI20000501 MY140507A (en) 2000-02-11 2000-02-11 Quinazoline derivatives, pharmaceutical compositions containing them, processes for their preparation and their use in the production of an antiangiogenic and/or vascular permeability reducing effect

Publications (1)

Publication Number Publication Date
MY140507A true MY140507A (en) 2009-12-31

Family

ID=45699639

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI20000501 MY140507A (en) 2000-02-11 2000-02-11 Quinazoline derivatives, pharmaceutical compositions containing them, processes for their preparation and their use in the production of an antiangiogenic and/or vascular permeability reducing effect

Country Status (1)

Country Link
MY (1) MY140507A (en)

Similar Documents

Publication Publication Date Title
SK500022013A3 (en) Quinazoline derivates as angiogenesis inhibitors
CA2344290A1 (en) Quinazoline derivatives
EP0654032A1 (en) Quinuclidine derivatives as squalene synthase inhibitors.
MY140507A (en) Quinazoline derivatives, pharmaceutical compositions containing them, processes for their preparation and their use in the production of an antiangiogenic and/or vascular permeability reducing effect
DE69315307D1 (en) Chimuclidine derivatives as squalene synthetase inhibitors